Skip to content
Screener

Dianthus Therapeutics DNTH Q2 2026 earnings

Reported August 4, 2026 · After market close

Revenue$761.0KBeat by $463.8K
EPS-$0.90Miss by $0.05
Revenue estimate$297.2K
EPS estimate-$0.85

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$443.9K
EPS estimate-$0.94

FAQ

When did Dianthus Therapeutics report Q2 2026 earnings?
Dianthus Therapeutics (DNTH) reported Q2 2026 earnings on August 4, 2026 after market close.
What were Dianthus Therapeutics's Q2 2026 revenue and EPS?
Dianthus Therapeutics reported revenue of $761.0K and eps of $-0.90 for Q2 2026.
Did Dianthus Therapeutics beat estimates in Q2 2026?
Revenue beat the consensus estimate of $297.2K by $463.8K. EPS missed the consensus estimate of $-0.85 by $0.05.
How did Dianthus Therapeutics's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 294.3% from $193.0K a year earlier and eps declined 2.3% from $-0.88.
Where can I find Dianthus Therapeutics's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001690585-26-000033) and the 10-Q periodic report (0001690585-26-000034) directly on SEC EDGAR. The filing index links above go to sec.gov.